Targeted inactivation of the Septin2 and Septin9 genes in myelinating Schwann cells of mice.

Martens, Ann-Kristin; Erwig, Michelle; Patzig, Julia; Fledrich, Robert; Füchtbauer, Ernst-Martin; Werner, Hauke B

Martens, Ann-Kristin; Erwig, Michelle; Patzig, Julia; Fledrich, Robert; Füchtbauer, Ernst-Martin; Werner, Hauke B.

Afiliación

Martens AK; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
Erwig M; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
Patzig J; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
Fledrich R; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
Füchtbauer EM; Department of Molecular Biology and Genetics, Aarhus University, Aarhus C, Denmark.
Werner HB; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.

Cytoskeleton (Hoboken) ; 80(7-8): 290-302, 2023.

Article en En | MEDLINE | ID: mdl-36378242

Palabras clave

Charcot-Marie-Tooth (CMT) disease; Schwann cell; Septin 2; Septin 9; hereditary neuralgic amyotrophy (HNA); myelin outfoldings; myelin sheath; tomaculae

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cytoskeleton (Hoboken) Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google